Previsioni

Il prezzo obiettivo medio degli analisti è +12,88€ (+36,44%). La mediana è +12,88€ (+36,44%).

Acquista	20
Mantieni	21
Vendi	1

Notizie Vai al feed delle notizie

FMC stock falls sharply after results and unchanged outlook

FMC’s stock plunged in pre-market trading after the company’s adjusted operating result in the second quarter surprised positively, but it confirmed its full-year outlook. Analysts at JPMorgan and UBS warned this could lead to lower estimates for the second half of the year. Bernstein also criticized weaker treatment numbers in the U.S.; the stock lost more than eight percent on Tradegate. » Altro su de.investing.com
FMC hits 52-week low at $10.55 amid high debt and asset sales

FMC shares fell to a 52-week low of $10.55, down 74.28% year‑over‑year. The company carries $4.66 billion in debt and a negative free cash flow (-$219.8 million). Tessenderlo is investing $400 million for a 20% stake to help reduce debt; FMC is also selling a parcel in Delaware for about $114 million and has filed an EPA registration dossier for the herbicide Rimisoxafen. BMO Capital reiterates a "Market Perform" rating, citing planned asset sales and the 2026 outlook. » Altro su de.investing.com
Exane BNP downgrades FMC and halts recent stock rally

Exane BNP has downgraded FMC from “Neutral” to “Underperform”, after which the stock fell about 2.2% to just under €43. Analyst Hugo Solvet expects persistently lower treatment volumes in the US dialysis market and points to lowered consensus estimates despite share gains year-to-date. The downgrade for now ends the recovery following the recent high reached in November. » Altro su de.investing.com

Dividendi storici Dividendi

Tutte le metriche sui dividendi Tutte le metriche

Nel 2026, FMC Corp ha già distribuito 0,21€ di dividendi. L'ultimo pagamento è avvenuto a luglio.

Dati finanziari dell'azienda

Nell'ultimo trimestre, FMC Corp ha registrato ricavi pari a 759,76M€ e un utile netto di −163,50M€

(EUR)	giu 2026	YoY
Ricavi	+759,76M	14,75%
Utile lordo	+299,75M	13,26%
Utile netto	−163,50M	388,92%
EBITDA	−71,76M	149,73%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	+1,20Mld€
Numero di azioni	125,23M
Massimo/minimo a 52 settimane	+34,34€ - +8,54€
Rendimento da dividendo	+7,50%
Dividendi TTM	+0,70€
Beta	0,41
Rapporto P/E	−0,51
Rapporto PEG	0,00
Rapporto P/B	+0,85
Rapporto P/S	+0,43

Profilo aziendale

FMC Corporation, ein Unternehmen der Agrarwissenschaften, bietet Produkte für den Pflanzenschutz, die Pflanzengesundheit und die professionelle Schädlingsbekämpfung und Rasenpflege an. Das Unternehmen entwickelt, vermarktet und verkauft chemische Pflanzenschutzmittel, darunter Insektizide, Herbizide und Fungizide, sowie biologische Produkte, Pflanzennahrung und Saatgutbehandlungsmittel, die in der Landwirtschaft zur Steigerung der Ernteerträge und -qualität durch die Bekämpfung einer Reihe von Insekten, Unkräutern und Krankheiten sowie in nicht-landwirtschaftlichen Märkten zur Schädlingsbekämpfung eingesetzt werden. Das Unternehmen vermarktet seine Produkte über seine eigene Vertriebsorganisation sowie über Allianzpartner, unabhängige Händler und Handelsvertreter. Das Unternehmen ist in Nordamerika, Lateinamerika, Europa, dem Nahen Osten, Afrika und Asien tätig. Die FMC Corporation wurde 1883 gegründet und hat ihren Hauptsitz in Philadelphia, Pennsylvania.

Nome	FMC Corp
CEO	Pierre R. Brondeau
Sede centrale	Philadelphia, pa Stati Uniti
Sito web	fmc.com
Settore	Materiali
Industria	Prodotti chimici
Quotazione in borsa	17/03/1980
Dipendenti	5.500